From: Cancer-associated adipocytes as immunomodulators in cancer
Immune cells | Mechanism | Alternations | References |
---|---|---|---|
Tumor-associated neutrophils (TANs) | Glycolysis↑ FFA uptake↑ A3R activation | ↑differentiation ↑ARG1 | |
Natural killer cells | MYC ↓ mTORC1↓→glycolysis↓, OXPHOS↓ Lipid accumulation↑ | ↓IFN-γ ↓Granzymes ↓Perforin ↑Apoptosis | |
Natural killer T cells | CD1d↓ | ↓Effector function | |
Tumor-associated macrophages (TAMs) | HIF1α stabilization → glycolysis PPAR-γ, PGC-1β↑→FFA uptake, oxidation↑ GPR132 activation CD39 CD73↑→A2BR activation | ↑M2-like polarization ↑ARG1 ↑VEGF | |
Myeloid-derived suppressor cells (MDSCs) | PUFAs→ immune suppression↑ CSF→ lipid metabolism↑ | ↓T cell activation | |
Dendritic cells | mTORC1/HIF1/NOS2↓→glycolysis↓ Lipid accumulation↑ PKA/Epac↑ GPR8 activation | ↓antigen-presentation function ↑IL-10 ↓IL-12 | |
Regulatory T cells | CD36↑→ FFA uptake, oxidation↑ PPAR-γ↑ MCT1↑ → OXPHOS↑ CD39↑→A2AR activation | ↑Differentiation ↑Proliferation | |
Effector T cells | Glycolysis↓ OXPHOS↓ CPT1α↑ → FAO↑ | ↓Effector function ↓Proliferation ↓Cytokine production ↑PD1 |